{"id":"W2044227111","doi":"10.1200/jco.2006.10.3051","title":"Vascular Endothelial Growth Factor Levels in Immunodepleted Plasma of Cancer Patients As a Possible Pharmacodynamic Marker for Bevacizumab Activity","year":2007,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Pharmacodynamics; Vascular endothelial growth factor; Cancer; Surrogate endpoint; Pharmacology; Internal medicine; Cancer research; Oncology; VEGF receptors; Pharmacokinetics; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001487639,0.0003706109,0.001773315,0.0002188788,0.00003798868,0.000009911266,0.0005625841,0.002313093,0.0001635879],"category_scores_gemma":[0.001385062,0.0003040165,0.001620415,0.0001148157,0.0002112419,0.00001347648,0.0001286228,0.001446141,0.000002434148],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002316601,"about_ca_system_score_gemma":0.00228843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002173809,"about_ca_topic_score_gemma":0.0001213414,"domain_scores_codex":[0.9957059,0.0005195966,0.002366445,0.0004529576,0.0004593324,0.0004957421],"domain_scores_gemma":[0.9945459,0.0009171822,0.003205274,0.0002636627,0.0009400842,0.0001279089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03838577,0.005225048,0.2081679,0.001054602,0.0106737,0.0004908098,0.0001098414,0.00009154955,0.1036833,0.000006629873,0.3345931,0.2975178],"study_design_scores_gemma":[0.01709837,0.00784674,0.1459856,0.0001906554,0.0005790309,0.00002388052,0.000007300162,0.00007709999,0.02257725,0.00004925538,0.8050223,0.0005424551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848471,0.001250388,0.0002762087,0.009355667,0.002833908,0.0004899404,0.0007538433,0.000002811391,0.0001901576],"genre_scores_gemma":[0.9161211,0.004710549,0.0007183396,0.07067126,0.006809926,0.00005251696,0.0001168434,0.0001230997,0.000676359],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4704293,"threshold_uncertainty_score":0.9999412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06697504993204398,"score_gpt":0.4280780077759488,"score_spread":0.3611029578439049,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}